2086-LB: Islet Surface Modification with Bissulfosuccinimidyl Suberate Prevents the Instant Blood-Mediated Inflammatory Reaction—A Novel Approach
Introduction and Objectives: In pancreatic islet cell transplantation, the early graft loss is due to the instant blood-mediated reaction (IBMIR). Control of early inflammatory events could improve the efficacy of islet cell transplantation and may enhance the long-term function of transplanted isle...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction and Objectives: In pancreatic islet cell transplantation, the early graft loss is due to the instant blood-mediated reaction (IBMIR). Control of early inflammatory events could improve the efficacy of islet cell transplantation and may enhance the long-term function of transplanted islets. Nanoencapsulation of islets is an attractive method for masking cell features that can trigger inflammatory cascades. Bissulfosuccinimidyl suberate (BS3) is a homobifunctional crosslinker with NHS ester on each side to bind to amine groups. Herein, we investigated the effects of BS3-modified human islets in terms of viability, function, longevity of modification, and inflammatory properties.
Methods: The surface of the human islets was modified with BS3 in different concentrations (0.5, 1, and 5 mM). Visual coverage and efficiency of surface conjugation were determined by incorporating an Amine-PEG-Biotin conjugate. Surface-conjugated islets were then cultured for 7 days. Visualization of conjugation and viability determination was performed days 0, 1, 4, and 7 of culture. The impact of BS3 conjugation on islet function was determined by measuring the oxygen consumption rates and glucose-stimulated insulin secretion.
Results: BS3 modification was found to be exceptionally biocompatible. The viability and functional integrity of islets were not altered at 0.5 mM and 1 mM BS3, but viability showed a mild decline at 5 mM BS3. However, improved conjugation of the islet surface and good coverage were noted in the 5 mM BS3 group. The surface modification was maintained for all 7 days tested with minimal loss of coverage. The markers of inflammation were examined using qPCR analysis. BS3 treated group showed higher inhibition of all pro-inflammatory genes under strong cytokine cocktail exposure.
Conclusion: Surface modification of islets with BS3 is a safe and tolerable approach that may be used for localized drug delivery strategies. |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db24-2086-LB |